Merck Seeks First U.S. Authorization for COVID-19 Pill

Translator

Tempo.co

Editor

Laila Afifa

12 October 2021 16:20 WIB

TEMPO.CO, JakartaMerck & Co Inc said on Monday, Oct. 11, it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.
An authorization from the U.S. Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken at home.

The treatment, molnupiravir, cut the rate of hospitalization and death by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to data released earlier this month.

The interim efficacy data on the drug, developed with Ridgeback Biotherapeutics, had heavily dented the shares of COVID-19 vaccine makers and set off a scramble among nations, including Malaysia, South Korea and Singapore, to sign a supply deal with Merck.

The drugmaker has a U.S. government contract to supply 1.7 million courses at a price of $700 per course. Merck expects to produce 10 million courses of the treatment by the end of 2021.

It has also agreed to license the drug to several India-based generic drugmakers, which are expected to supply the treatment to more than 100 low- and middle-income countries. Gilead Sciences Inc's infused antiviral remdesivir is generally given only once a patient is hospitalized.

Monoclonal antibody drugs from Regeneron Pharmaceuticals Inc and Eli Lilly, which are typically infused as well, have so far seen only limited use due to the difficulty in administering them. Merck's shares opened roughly 1% higher before paring some gains to trade at $81.32.

Read: Govt Monitors Prices of Covid-19 Drugs Sold in Public

REUTERS



Covid-19 Pandemic Could Soon End, Says President Jokowi

3 hari lalu

Covid-19 Pandemic Could Soon End, Says President Jokowi

Jokowi hinted at the possibility that the government will announce the end of the Covid-19 pandemic.


Jakarta the Highest Contributor of Covid-19 Positive Cases Today: Health Ministry

4 hari lalu

Jakarta the Highest Contributor of Covid-19 Positive Cases Today: Health Ministry

The number of positive confirmed cases of COVID-19 on Sunday, October 2, 2022, increased by 1,322 cases with Jakarta contributed the highest number.


Taiwan to End COVID-19 Quarantine for Arrivals, Welcome Back Tourists

6 hari lalu

Taiwan to End COVID-19 Quarantine for Arrivals, Welcome Back Tourists

Taiwan says arrivals will still need to monitor their health for a seven-day period and take rapid tests, but tourists will be allowed to return.


Six People Injured in Shooting at U.S. Public School

6 hari lalu

Six People Injured in Shooting at U.S. Public School

Six people were injured in a mass shooting at an Oakland public school, in the western U.S. state of California, on Wednesday.


Jokowi Will Not Follow Joe Biden and Declare 'Pandemic is Over'

16 hari lalu

Jokowi Will Not Follow Joe Biden and Declare 'Pandemic is Over'

Jokowi prefers to wait for a decision from the World Health Organization (WHO).


Police Foil Attempt of 304kg Drug Smuggling in Vegetable Truck

19 hari lalu

Police Foil Attempt of 304kg Drug Smuggling in Vegetable Truck

Four perpetrators are arrested in the drug smuggling attempt.


Boeing Plans to Remarket 737 MAX Jets for Chinese Airlines

20 hari lalu

Boeing Plans to Remarket 737 MAX Jets for Chinese Airlines

Boeing says in July that it had about 290 undelivered airplanes and about half were designated for Chinese customers.


Malaysia Urges ASEAN to Speed Up Post-pandemic Recovery Initiatives

22 hari lalu

Malaysia Urges ASEAN to Speed Up Post-pandemic Recovery Initiatives

ASEAN must speed up the initiatives under the ASEAN Comprehensive Recovery Framework (ACRF) to face rising uncertainties in the current global economy


IDI Encourages Booster Vaccination to Reach Endemic Level

23 hari lalu

IDI Encourages Booster Vaccination to Reach Endemic Level

The COVID-19 Task Force Head of the Indonesian Medical Association (IDI), Erlina Burhan, encourages the public to immediately get booster shots.


Indonesia Adds New 1,848 COVID-19 Cases

24 hari lalu

Indonesia Adds New 1,848 COVID-19 Cases

The COVID-19 Handling Task Force recorded an additional 1,848 COVID-19 infections as of 12 p.m. local time on Monday